Re:NewCell’s Shares Offering

Baker McKenzie advised Nordea and Pareto on the deal. Vinge has advised Re:NewCell. Re:NewCell AB (publ) has carried out a primary issuance of shares of approximately...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Xbrane Biopharma’s Shares Offering

Baker McKenzie advised Xbrane Biopharma on the deal. Xbrane Biopharma AB (publ) executed a primary issuance of shares of approximately SEK 170 million at a subscription price...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

BioInvent’s Shares Offering

Baker McKenzie acted as legal advisor to Kempen & Co and Pareto Securities on the deal. BioInvent International has carried out a primary issuance of shares...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Swedencare’s Shares Offering

Baker McKenzie acted as legal advisor to the Joint Bookrunners. Lindahl advised Swedencare AB. Swedencare AB (publ) has carried out a primary issuance of shares of...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

SEBA Bank’s Series C Capital Raising

Baker McKenzie advised SEBA Bank on the deal. MLL advised Julius Baer. SEBA Bank AG raised CHF 110 million through the issuance of participation certificates (non-voting...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here